Cargando…

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer

A large proportion of anti-tumor immunity research is focused on major histocompatibility complex class I (MHC-I) molecules and CD8(+) T cells. Despite mounting evidence has shown that CD4(+) T cells play a major role in anti-tumor immunity, the role of the MHC-II molecules in tumor immunotherapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Ruibin, Hong, Shuo, Zhang, Yueming, Lin, Anqi, Ying, Haoxuan, Zou, Weidong, Wang, Qiongyao, Wei, Ting, Cheng, Quan, Zhu, Weiliang, Luo, Peng, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873787/ https://www.ncbi.nlm.nih.gov/pubmed/35223828 http://dx.doi.org/10.3389/fcell.2022.757137

Ejemplares similares

Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer
por: Li, Pengju, et al.
Publicado: (2021)

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
por: Lei, Qingyang, et al.
Publicado: (2020)

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
por: Fu, Yuyin, et al.
Publicado: (2021)

Highly Water-Preserving Zwitterionic Betaine-Incorporated Collagen Sponges With Anti-oxidation and Anti-inflammation for Wound Regeneration
por: Chen, Anqi, et al.
Publicado: (2020)

Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
por: Hong, Shuo, et al.
Publicado: (2021)

Integration of cancer stemness and neoantigen load to predict responsiveness to anti-PD1/PDL1 therapy
por: Luo, Kunpeng, et al.
Publicado: (2022)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2021)

New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer
por: Jiang, Yi, et al.
Publicado: (2022)

Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer
por: Fu, Qiang, et al.
Publicado: (2021)

Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy
por: Fan, Xiaona, et al.
Publicado: (2021)

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas
por: Li, Depei, et al.
Publicado: (2021)

Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers
por: Mo, Shu-Fen, et al.
Publicado: (2023)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

The Anti-apoptotic Role of 3′-Untranslational Region in Response to Angiotensin II via Mcl1 Expression
por: Lyu, Dayin, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
por: Qian, Hao, et al.
Publicado: (2021)

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Transcriptomic Signatures of Airway Epithelium Infected With SARS-CoV-2: A Balance Between Anti-infection and Virus Load
por: Meng, Lingzhang, et al.
Publicado: (2021)

EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway
por: Luo, Ke-Wang, et al.
Publicado: (2020)

TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer
por: Tu, Yaofen, et al.
Publicado: (2022)

Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer
por: Liang, Xiaolong, et al.
Publicado: (2022)

REG4 promotes the proliferation and anti-apoptosis of cancer
por: Zheng, Hua-Chuan, et al.
Publicado: (2022)

Identification and Development of Inflammatory Response–Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer
por: Zheng, Haoxiang, et al.
Publicado: (2022)

Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ(+) CD4(+) T Cells Through Enhancing IκBα Degradation and NF-κB Activation
por: Li, Xiang, et al.
Publicado: (2021)

Identification and validation of the diagnostic signature associated with immune microenvironment of acute kidney injury based on ferroptosis-related genes through integrated bioinformatics analysis and machine learning
por: Chen, Yalei, et al.
Publicado: (2023)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

Exosomes as Drug Carriers in Anti-Cancer Therapy
por: Chen, Lan, et al.
Publicado: (2022)

Inflammasomes in Cancer Progression and Anti-Tumor Immunity
por: Lillo, Sebastian, et al.
Publicado: (2022)

Atlantic cod (Gadus morhua) MHC I localizes to endolysosomal compartments independently of cytosolic sorting signals
por: Bjørnestad, Synne Arstad, et al.
Publicado: (2023)

Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR’s Anti-apoptotic Function at Mitochondria, and the Implications in Cancer
por: Makinwa, Yetunde, et al.
Publicado: (2020)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

DHOK Exerts Anti-Cancer Effect Through Autophagy Inhibition in Colorectal Cancer
por: Shu, Yuhan, et al.
Publicado: (2021)

Modeling Inflammation in Zebrafish for the Development of Anti-inflammatory Drugs
por: Xie, Yufei, et al.
Publicado: (2021)

Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients
por: Gu, Hongbing, et al.
Publicado: (2022)

Selective Anti-melanoma Effect of Phosphothioated Aptamer Encapsulated by Neutral Cytidinyl/Cationic Lipids
por: Wu, Jing, et al.
Publicado: (2021)

Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
por: Comunanza, Valentina, et al.
Publicado: (2017)

Emerging roles of purinergic signaling in anti-cancer therapy resistance
por: Zanoni, Michele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2g3ncrg2j5hodkt6s0qfgouvou